IZABELA HORZEMPA: Open Payments
NPI 1295426781 · MADISON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,223 in 258 payments from 19 companies in 2025. Trend: 2023 $1,313 · 2024 $5,593 · 2025 $8,223
Food & beverage: $6,954Consulting: $1,064Education: $206
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 32 | $1,727 |
| ABBVIE INC. | 62 | $1,104 |
| Janssen Biotech, Inc. | 23 | $904 |
| Journey Medical Corporation | 5 | $900 |
| UCB, Inc. | 24 | $686 |
| GENZYME CORPORATION | 13 | $483 |
| Incyte Corporation | 16 | $436 |
| Novartis Pharmaceuticals Corporation | 18 | $352 |
| Arcutis Biotherapeutics, Inc. | 7 | $302 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $299 |
Products named: ANZUPGO, TREMFYA, Bimzelx, DUPIXENT, SKYRIZI, ADBRY, RINVOQ, OPZELURA.
Industry payments across CT — which companies pay providers there.
